4.7 Article

Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer

期刊

ANALYTICAL AND BIOANALYTICAL CHEMISTRY
卷 401, 期 1, 页码 149-165

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00216-011-5020-5

关键词

MALDI mass spectrometry imaging; Principal component analysis; Symbolic discriminant analysis; Hierarchical clustering; Bottom-up; In-source decay; Biomarkers; Prostate cancer

资金

  1. Centre National de la Recherche Scientifique (CNRS)
  2. Ministere de L'Education Nationale
  3. de L'Enseignement Superieur et de la Recherche
  4. Agence Nationale de la Recherche (ANR PCV)
  5. Institut du Cancer (INCA)
  6. Region Nord-Pas de Calais
  7. Canadian Institutes of Health Research (CIHR
  8. Ministere du Developpement Economique
  9. de l'Innovation et de l'Exportation (MDEIE) du Quebec
  10. Fonds de recherche en sante du Quebec (FRSQ)

向作者/读者索取更多资源

The large amount of data generated using matrix-assisted laser desorption/ionization mass spectrometric imaging (MALDI-MSI) poses a challenge for data analysis. In fact, generally about 1.10(8)-1.10(9) values (m/z, I) are stored after a single MALDI-MSI experiment. This imposes processing techniques using dedicated informatics tools to be used since manual data interpretation is excluded. This work proposes and summarizes an approach that utilizes a multivariable analysis of MSI data. The multivariate analysis, such as principal component analysis-symbolic discriminant analysis, can remove and highlight specific m/z from the spectra in a specific region of interest. This approach facilitates data processing and provides better reproducibility, and thus, broadband acquisition for MALDI-MSI should be considered an effective tool to highlight biomarkers of interest. Additionally, we demonstrate the importance of the hierarchical classification of biomarkers by analyzing studies of clusters obtained either from digested or undigested tissues and using bottom-up and in-source decay strategies for in-tissue protein identification. This provides the possibility for the rapid identification of specific markers from different histological samples and their direct localization in tissues. We present an example from a prostate cancer study using formalin-fixed paraffin-embedded tissue.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Spectroscopy

Neurotrauma investigation through spatial omics guided by mass spectrometry imaging: Target identification and clinical applications

Khalil Mallah, Kazem Zibara, Coline Kerbaj, Ali Eid, Nour Khoshman, Zahraa Ousseily, Abir Kobeissy, Tristan Cardon, Dasa Cizkova, Firas Kobeissy, Isabelle Fournier, Michel Salzet

Summary: Traumatic brain injury (TBI) is a major public health concern worldwide, and the use of proteomic and lipidomic platforms has broadened our understanding of TBI-related mechanisms and neuropathological complications. This study provides an updated overview of spatially resolved microproteomics and microlipidomics approaches guided by mass spectrometry imaging in TBI studies and discusses their applications in neurotrauma research. The accurate and precise techniques of microproteomic sampling, such as laser capture microdissection, parafilm assisted microdissection, and liquid microjunction extraction, are evaluated. The potential of lipid profiling, particularly in phospholipid metabolism and proinflammatory molecules, is highlighted.

MASS SPECTROMETRY REVIEWS (2023)

Article Biology

Establishment and characterization of canine mammary tumoroids for translational research

Antonella Raffo-Romero, Soulaimane Aboulouard, Emmanuel Bouchaert, Agata Rybicka, Dominique Tierny, Nawale Hajjaji, Isabelle Fournier, Michel Salzet, Marie Duhamel

Summary: Developing a robust canine mammary tumor model in the form of tumoroids has been achieved, which can replicate the diversity and heterogeneity of tumors. Canine tumoroids are a reliable drug screening model and can be cryopreserved to create a biobank.

BMC BIOLOGY (2023)

Review Oncology

Molecular prediction of clinical response to anti-PD-1/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigations

Remi Longuespee, Dirk Theile, Inka Zoernig, Jessica C. Hassel, Joshua Raoul Lindner, Walter E. Haefeli, Margaux Fresnais

Summary: Monoclonal antibodies acting as immune checkpoint inhibitors are widely used in oncology, but precision medicine approaches for personalized treatment are underutilized. Mass spectrometric approaches, coupled with new sample preparation methods, have the potential to stratify patients and detect resistance early on, providing valuable information for precision medicine.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Multidisciplinary Sciences

Employing non-targeted interactomics approach and subcellular fractionation to increase our understanding of the ghost proteome

Diego Fernando Garcia-del Rio, Tristan Cardon, Sven Eyckerman, Isabelle Fournier, Amelie Bonnefond, Kris Gevaert, Michel Salzet

Summary: Scientists used subcellular fractionation to increase information about alternative proteins (AltProts) and facilitate the detection of protein-protein interactions. A total of 112 unique AltProts were identified, with 16 identified crosslinks between AltProts and referenced proteins (RefProts). The study of the interactome and localization of AltProts reveals the importance of the ghost proteome.

ISCIENCE (2023)

Article Cell Biology

Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion

Alice Capuz, Sylvain Osien, Melodie Anne Karnoub, Soulaimane Aboulouard, Estelle Laurent, Etienne Coyaud, Antonella Raffo-Romero, Marie Duhamel, Amelie Bonnefond, Mehdi Derhourhi, Marco Trerotola, Ikram El Yazidi-Belkoura, David Devos, Monika Zilkova, Firas Kobeissy, Fabien Vanden Abeele, Isabelle Fournier, Dasa Cizkova, Franck Rodet, Michel Salzet

Summary: Using various omics analyses, we discovered that newborn rat astrocytes produce neural immunoglobulin chains with similarities to aberrant immunoglobulins found in cancers. The complete enzymatic V(D)J recombination complex was also found in astrocytes. In addition, we identified different immunoglobulin chains in adult rat astrocytes and primary astrocytes from human fetus. These neural IgGs play a role in astrocyte fate and interact with specific targets.

CELL DEATH & DISEASE (2023)

Article Oncology

Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study

Eric Leblanc, Fabrice Narducci, Gwenael Ferron, Audrey Mailliez, Jean-Yves Charvolin, El Hajj Houssein, Frederic Guyon, Virginie Fourchotte, Eric Lambaudie, Agathe Crouzet, Yves Fouche, Sebastien Gouy, Pierre Collinet, Frederic Caquant, Christophe Pomel, Francois Golfier, Veronique Vaini-Cowen, Isabelle Fournier, Michel Salzet, Emmanuelle Tresch, Alicia Probst, Anne-Sophie Lemaire, Marie-Cecile Le Deley, Delphine Hudry

Summary: A two-step approach of radical fimbriectomy followed by delayed oophorectomy appears to be a safe and well-tolerated method for reducing the risk of ovarian cancer in high-risk women, avoiding surgery-induced early menopause.

CANCERS (2023)

Article Chemistry, Analytical

Early Diagnosis: End-to-End CNN-LSTM Models for Mass Spectrometry Data Classification

Khawla Seddiki, Frederic Precioso, Melissa Sanabria, Michel Salzet, Isabelle Fournier, Arnaud Droit

Summary: Liquid chromatography-mass spectrometry (LC-MS) is a powerful method for cell profiling in cancer research. However, the presence of noise, peak shifts, and high dimensionality of the data make early cancer diagnosis challenging. This study proposes an end-to-end deep learning methodology that addresses these challenges and preserves the potential of LC-MS data.

ANALYTICAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Development of a novel apigenin prodrug programmed for alkaline-phosphatase instructed self-inhibition to combat cancer

Dimitrios Diamantis, Antonios D. Tsiailanis, Christina Papaemmanouil, Maria-Christina Nika, Zoi Kanaki, Simona Golic Grdadolnik, Andrej Babic, Eleftherios Paraskevas Tzakos, Isabelle Fournier, Michel Salzet, Prem Prakash Kushwaha, Nikolaos S. Thomaidis, Theodoros Rampias, Eswar Shankar, Serdar Karakurt, Sanjay Gupta, Andreas G. Tzakos

Summary: A novel prodrug approach was developed to inhibit cancer progression by targeting alkaline phosphatase (ALP) in the tumor microenvironment (TME). The prodrug, phospho-apigenin, increased the stability of apigenin and showed enhanced antiproliferative effect in malignant cells with elevated ALP levels compared to apigenin alone. In vivo experiments also demonstrated its significant tumor growth suppression.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Correction Cell Biology

Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome ( vol 14 , 677 , 2023)

Alice Capuz, Sylvain Osien, Tristan Cardon, Melodie Anne Karnoub, Soulaimane Aboulouard, Antonella Raffo-Romero, Marie Duhamel, Dasa Cizkova, Marco Trerotola, David Devos, Firas Kobeissy, F. Vanden Abeele, Amelie Bonnefond, Isabelle Fournier, Franck Rodet, Michel Salzet

CELL DEATH & DISEASE (2023)

Article Biochemical Research Methods

Protocol to identify human subcellular alternative protein interactions using cross-linking mass spectrometry

Diego Fernando Garcia-del Rio, Isabelle Fournier, Tristan Cardon, Michel Salzet

Summary: This study presents a protocol for identifying human subcellular AltProts and deciphering their interactions using cross-linking mass spectrometry. The protocol includes steps for cell culture, in cellulo cross-linking, subcellular extraction, and sequential digestion, as well as liquid chromatography-tandem mass spectrometry and cross-link data analyses. The implementation of this workflow allows for the non-targeted identification of signaling pathways involving AltProts.

STAR PROTOCOLS (2023)

Review Oncology

Challenges in glioblastoma research: focus on the tumor microenvironment

Andreas Bikfalvi, Cristine Alves da Costa, Tony Avril, Jean-Vianney Barnier, Luc Bauchet, Lucie Brisson, Pierre Francois Cartron, Helene Castel, Eric Chevet, Herve Chneiweiss, Anne Clavreul, Bruno Constantin, Valerie Coronas, Thomas Daubon, Monique Dontenwill, Francois Ducray, Natacha Entz-Werle, Dominique Figarella-Branger, Isabelle Fournier, Jean-Sebastien Frenel, Mathieu Gabut, Thierry Galli, Julie Gavard, Gilles Huberfeld, Jean-Philippe Hugnot, Ahmed Idbaih, Marie-Pierre Junier, Thomas Mathivet, Philippe Menei, David Meyronet, Celine Mirjolet, Fabrice Morin, Jean Mosser, Elisabeth Cohen-Jonathan Moyal, Veronique Rousseau, Michel Salzet, Marc Sanson, Giorgio Seano, Emeline Tabouret, Aurelie Tchoghandjian, Laurent Turchi, Francois M. Vallette, Somya Vats, Maite Verreault, Thierry Virolle

Summary: Glioblastoma (GBM) is a highly lethal brain tumor, and recent studies have emphasized the importance of the tumor microenvironment (TME) as a therapeutic target. However, a comprehensive understanding of the different cellular and molecular components involved in the GBM TME and their interactions is still needed for the development of more effective treatments. This review presents a comprehensive report on the GBM TME, combining the contributions of researchers and physicians in France, and provides a holistic view of the subject by describing the specific features of the GBM TME at the cellular, molecular, and therapeutic levels.

TRENDS IN CANCER (2023)

Article Endocrinology & Metabolism

Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study

Lise Folon, Morgane Baron, Benedicte Toussaint, Emmanuel Vaillant, Mathilde Boissel, Victoria Scherrer, Helene Loiselle, Audrey Leloire, Alaa Badreddine, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Soulaimane Aboulouard, Michel Salzet, Mickael Canouil, Mehdi Derhourhi, Philippe Froguel, Amelie Bonnefond

Summary: Rare biallelic pathogenic mutations in PCSK1 cause early-onset obesity and other endocrinopathies. Functional genomic study shows that rare heterozygous variants of PCSK1 can also impact obesity risk.

LANCET DIABETES & ENDOCRINOLOGY (2023)

暂无数据